Skip to main content
. 2017 Mar 28;8:54–62. doi: 10.1016/j.idcr.2017.03.012

Table 1.

Epidemiology of C. difficile bacteremias reported in the literature.

Period Country Number of CDB casesa Incidence Reference
1962–1969 USA 3 Isolates/86 nonhistotoxic clostridial bacteremias (laboratory isolates)* 0.4 [42], [52]
15 months USA 1 Blood culture isolate (Anaerobe study)* 0.8 [53]
14 months USA 1 CDB/2168 bacteremias* 0.9 [30]
1985–1995 USA 3 CDB/14 ECD2 0.3 [31]
1990–1997 USA 1/164 304 hospitalizations* 0.13 [32]
1990–2000 Spain 2 CDB/21 ECD (50 000 admissions/year)b 0.2 [33]
1988–2003 USA 2 Blood culture isolates/25 ECD* 0.2 [34]
2000–2006 Canada 7 CDB/1.2 million residents* 1 [35]
2004–2008 UK 62 CDB/320 371 bacteremias* 9 to 17 [36], [37]
2008–2012 UK 0 0 [38]
2010–2014 UK 0 0 [39]
1989–2009 Taiwan 12 CDB/2 medical centersb,c 0.6 [43]
2002–2012 Finland 2 CDB/31 ECDb 0.2 [54]
2004–2013 USA 11 CDB/40 ECD/6525 CDIb 1.1 [28]
1962–2016 All countries Total: 137 (the 58 published casesb, the two present casesb and 77* cases in other reports) Present review
a

CDB cases of each study or literature review when clearly mentioned in articles or reports.

b

Cases with clinical data reported in Table 2.

c

1100-bed and 2800-bed tertiary-care hospitals in Taiwan.

*

Cases not available with clinical data but exposed in other reports in the reviewed literature.